ãµã³ã¿ã»ãšãŠã©ãªã¢ã»ããã«ïŒã¹ãã®ãžã ã¯ãã¢ãã³ã§å®çšçãªèšåãåããŠããŸãããå©çšã«ã¯è¿œå æéãå¿
èŠã§ãã宿æ³å®¢ã¯ãçŽ æŽããããã·ã³ãããªãŒãŠã§ã€ããªã©ã質ã®é«ããã£ãããã¹èšåãæŽã£ãŠãããæå
¥ããè¡ãå±ããŠããŠæž
æœã ãšè¿°ã¹ãŠããŸãããžã ã¯ã¹ãè€åæœèšã®äžéšã§ãããå°è±¡çãªãã£ãããã¹ãªãœãŒã¹ãåããŠããã«ãããããããæ¹ä¿®å·¥äºãCOVID-19ã®å¶éã«ãããå©çšãå¶éãããå ŽåããããŸãã
ãžã ã®å©çšæéã¯ã1人1æ¥ããã7.50ãŠãŒãã«èšå®ãããŠããã宿æ³å®¢ã®äžã«ã¯ãæ»åšåã«ååã«åç¥ãããŠããªãã£ããšæãã人ãããŸãããåå10æããã®å¶æ¥æéã¯ãæ©æã«éåããã人ã«ã¯åããªããããããŸããããŸããè€æ°æ¥å©çšã®ç¹å¥æéããªãããšããäžäŸ¿ã«æãã人ãããã§ãããããããã®åé¡ã«ããããããããžã ãå©çšã§ãã宿æ³å®¢ã¯ãæŠãã¯ãŒã¯ã¢ãŠãã®ããŒãºã«å¿ãããããŸãšããªæœèšã ãšæããŠããŸãã
ã¿ãªã«ã¯æäŸãããŠããããå€æãæ¹ä¿®æéäžã¯ãžã ãå©çšã§ããªãå Žåãããããšã«æ³šæããŠãã ããããã£ãããã¹ç¿æ
£ãç¶æãããã²ã¹ãã«ãšã£ãŠããµã³ã¿ã»ãšãŠã©ãªã¢ã»ããã«ïŒã¹ãã®ãžã ã¯ãããŒã«ã®ç®ã®åã«ãããææã§ã¯ãããã®ã®ãåªãããã£ãããã¹æœèšãæäŸããŠããŸãã